Independence equals creativity, and solutions
Global holding companies are, in reality, nothing more than loose confederations of independent agencies, each with their own profit and loss statements (P&Ls) and profit goals. This can create multiple layers of unnecessary bureaucracy and overhead, actually resulting in increased cost to the client.
Jamie Peck
In a word, independence gives birth to creativity. Rosetta's point of view is that independent alliances, while sometimes hard to centrally manage, are the most effective way to serve our global clients creatively. For Allergan EMEA, Rosetta has acted as a sole provider of all digital solutions in 11 countries. This has resulted in several award-winning digital solutions, all managed centrally from the US.
By recognizing the inverse dynamic of emerging media in emerging regions, HC marketers can leverage the power of an entire arsenal of tools. Outside of the US, the Web is merely a portal or gateway for the patient and provider to access a myriad of other digitally enabled media outlets. By accessing these other channels (mobile, social, gaming, etc.), we are able to meet all of the targets' needs—emotional, educational, and value based—through the devices they rely on every day.
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
February 4th 2025Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye injections.
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
January 30th 2025Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.